LENNAR CORP /NEW/ (LEN) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-05-31..
- Stock-based compensation / revenue · 12 months: Value 0.43%; Formula and calculation Share-based compensation / revenue. Period ending 2026-05-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.43% | Share-based compensation / revenue. Period ending 2026-05-31. $139.28M ÷ $32.74B × 100 ≈ 0.43% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 32.74B USD | |
| Stock-based compensation | 139.28M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | (m) | $32.74B | $139.28M | (m) | (m) | (m) | 0.43% | (m) | (m) |
| 2026-02-28 | (m) | $33.17B | $141.79M | (m) | (m) | (m) | 0.43% | (m) | (m) |
| 2025-11-30 | (m) | $34.19B | $163.49M | (m) | (m) | (m) | 0.48% | (m) | (m) |
| 2025-08-31 | (m) | $34.77B | $160.94M | (m) | (m) | (m) | 0.46% | (m) | (m) |
| 2025-05-31 | (m) | $35.37B | $167.35M | (m) | (m) | (m) | 0.47% | (m) | (m) |
| 2025-02-28 | (m) | $35.76B | $173.08M | (m) | (m) | (m) | 0.48% | (m) | (m) |
| 2024-11-30 | (m) | $35.44B | $176.68M | (m) | (m) | (m) | 0.50% | (m) | (m) |
| 2024-08-31 | (m) | $36.46B | $175.20M | (m) | (m) | (m) | 0.48% | (m) | (m) |
| 2024-05-31 | (m) | $35.78B | $156.18M | (m) | (m) | (m) | 0.44% | (m) | (m) |
| 2024-02-29 | (m) | $35.06B | $161.84M | (m) | (m) | (m) | 0.46% | (m) | (m) |
| 2023-11-30 | (m) | $34.23B | $160.72M | (m) | (m) | (m) | 0.47% | (m) | (m) |
| 2023-08-31 | (m) | (m) | $168.99M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-05-31 | (m) | (m) | $194.31M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-02-28 | (m) | (m) | $189.19M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-11-30 | (m) | (m) | $184.09M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-08-31 | (m) | (m) | $183.94M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-05-31 | (m) | (m) | $170.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-02-28 | (m) | $28.01B | $167.26M | (m) | (m) | (m) | 0.60% | (m) | (m) |
| 2021-11-30 | (m) | $27.13B | $134.62M | (m) | (m) | (m) | 0.50% | (m) | (m) |
| 2021-08-31 | (m) | $25.52B | $128.72M | $5.84B | (m) | (m) | 0.50% | (m) | (m) |
| 2021-05-31 | (m) | $24.45B | $132.63M | $4.86B | (m) | (m) | 0.54% | (m) | (m) |
| 2021-02-28 | (m) | $23.31B | $124.09M | $4.42B | (m) | (m) | 0.53% | (m) | (m) |
| 2020-11-30 | (m) | $22.49B | $107.13M | $3.48B | (m) | (m) | 0.48% | (m) | (m) |
| 2020-08-31 | (m) | $22.63B | $105.30M | $3.20B | (m) | (m) | 0.47% | (m) | (m) |
| 2020-05-31 | (m) | $22.62B | $110.69M | $3.01B | (m) | (m) | 0.49% | (m) | (m) |
| 2020-02-29 | (m) | $22.90B | $101.90M | $2.89B | (m) | (m) | 0.45% | (m) | (m) |
| 2019-11-30 | (m) | $22.26B | $86.94M | $2.78B | (m) | (m) | 0.39% | (m) | (m) |
| 2019-08-31 | (m) | $21.75B | $82.45M | $2.78B | (m) | (m) | 0.38% | (m) | (m) |
| 2019-05-31 | (m) | $21.56B | $70.33M | $2.68B | (m) | (m) | 0.33% | (m) | (m) |
| 2019-02-28 | (m) | $21.46B | $71.79M | $2.51B | (m) | (m) | 0.33% | (m) | (m) |
| 2018-11-30 | (m) | $20.57B | $72.66M | $2.46B | (m) | (m) | 0.35% | (m) | (m) |
| 2018-08-31 | (m) | $17.90B | $73.69M | $2.16B | (m) | (m) | 0.41% | (m) | (m) |
| 2018-05-31 | (m) | $15.49B | $70.26M | $1.93B | (m) | (m) | 0.45% | (m) | (m) |
| 2018-02-28 | (m) | $13.29B | $66.62M | $1.81B | (m) | (m) | 0.50% | (m) | (m) |
| 2017-11-30 | (m) | $12.65B | $61.36M | $1.48B | (m) | (m) | 0.49% | (m) | (m) |
| 2017-08-31 | (m) | $12.24B | $64.19M | $1.46B | (m) | (m) | 0.52% | (m) | (m) |
| 2017-05-31 | (m) | $11.81B | $58.07M | $1.42B | (m) | (m) | 0.49% | (m) | (m) |
| 2017-02-28 | (m) | $11.29B | $56.88M | $1.42B | (m) | (m) | 0.50% | (m) | (m) |
| 2016-11-30 | (m) | $10.95B | $55.52M | $1.56B | $4.63M | (m) | 0.51% | 337.88× | Reported |
| 2016-08-31 | (m) | $10.52B | $46.30M | $1.53B | $212.77M | (m) | 0.44% | 7.20× | Reported |
| 2016-05-31 | (m) | $10.18B | $45.49M | $1.51B | $214.61M | (m) | 0.45% | 7.03× | Reported |
| 2016-02-29 | (m) | $9.82B | $44.76M | $1.45B | (m) | (m) | 0.46% | (m) | (m) |
| 2015-11-30 | (m) | $9.47B | $43.87M | $1.43B | $220.15M | (m) | 0.46% | 6.48× | Reported |
| 2015-08-31 | (m) | $9.11B | $44.33M | $1.36B | (m) | (m) | 0.49% | (m) | (m) |
| 2015-05-31 | (m) | $8.63B | $44.08M | $1.29B | (m) | (m) | 0.51% | (m) | (m) |
| 2015-02-28 | (m) | $8.06B | $42.23M | $1.20B | (m) | (m) | 0.52% | (m) | (m) |
| 2014-11-30 | (m) | $7.78B | $40.72M | $1.15B | $201.54M | (m) | 0.52% | 5.69× | Reported |
| 2014-08-31 | (m) | $7.11B | $38.75M | $1.03B | (m) | (m) | 0.54% | (m) | (m) |
| 2014-05-31 | (m) | $6.70B | $37.79M | $953.20M | (m) | (m) | 0.56% | (m) | (m) |
| 2014-02-28 | (m) | $6.31B | $35.94M | $907.40M | (m) | (m) | 0.57% | (m) | (m) |
| 2013-11-30 | (m) | $5.94B | $33.69M | $828.00M | $214.26M | (m) | 0.57% | 3.86× | Reported |
| 2013-08-31 | (m) | $5.37B | $31.09M | $651.68M | (m) | (m) | 0.58% | (m) | (m) |
| 2013-05-31 | (m) | $4.87B | $29.01M | $515.62M | (m) | (m) | 0.60% | (m) | (m) |
| 2013-02-28 | (m) | $4.37B | $30.07M | $400.75M | (m) | (m) | 0.69% | (m) | (m) |
| 2012-11-30 | (m) | $4.10B | $31.75M | $349.45M | $181.38M | (m) | 0.77% | 1.93× | Reported |
| 2012-08-31 | (m) | $3.71B | $32.01M | $245.79M | (m) | (m) | 0.86% | (m) | (m) |
| 2012-05-31 | (m) | $3.43B | $28.47M | $201.72M | (m) | (m) | 0.83% | (m) | (m) |
| 2012-02-29 | (m) | $3.26B | $25.48M | $166.85M | (m) | (m) | 0.78% | (m) | (m) |
| 2011-11-30 | (m) | $3.10B | $24.05M | $193.23M | $162.97M | (m) | 0.78% | 1.19× | Reported |
| 2011-08-31 | (m) | $3.00B | $27.30M | (m) | (m) | (m) | 0.91% | (m) | (m) |
| 2011-05-31 | (m) | $3.01B | $27.94M | (m) | (m) | (m) | 0.93% | (m) | (m) |
| 2011-02-28 | (m) | $3.06B | $28.51M | (m) | (m) | (m) | 0.93% | (m) | (m) |
| 2010-11-30 | (m) | $3.07B | $28.07M | (m) | (m) | (m) | 0.91% | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-11-30 | (m) | $3.12B | $30.39M | (m) | (m) | (m) | 0.97% | (m) | (m) |
| 2009-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-11-30 | (m) | $4.58B | $29.87M | (m) | (m) | (m) | 0.65% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.